<unk>  was a non-drug, device-based treatment also known as Immune Modulation Therapy (IMT), developed by the Canadian-based biotherapeutics company Vasogen, Inc. for chronic heart failure and peripheral artery disease. Blood was piped through the device, where it was exposed to heat, ultraviolet light, and ozone, in the hope that this oxidative stress would trigger an anti-inflammatory immunomodulation response. Despite some promising early results and one positive result in subgroup analysis, the technique usually did not produce the hoped-for clinically significant results.
Celacade
Cloforex
Chemturion
Batea
Theriac
Midaflur
Amphinex
Choroid